ArticleMolecular cancer therapeutics2021

Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.

Katelyn F Handley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.